Tanini Annita
SEC insider (Form 3/4/5 filer). CIK 0002146784. Corp. Controller & VP, Finance at Keros Therapeutics, Inc. (KROS). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 18, 2026. Located in LEXINGTON, MA.
Companies Tanini Annita has filed insider reports for
- Keros Therapeutics, Inc. (KROS): Officer, Corp. Controller & VP, Finance
Tanini Annita
CIK: 0002146784
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KROS
Keros Therapeutics, Inc.
Officer